Arctech Inaugurates New European Headquarters in Madrid, Paving the Way for a Grand European Expansion

MADRID, Nov. 22, 2024 /PRNewswire/ — Arctech, the world’s leading solar tracking and racking solutions provider, celebrated the relocation of its European headquarters in Madrid, Spain, on November 18th with a ribbon cutting ceremony. The event was attended by Chairman and President Cai Hao, General Manager of EU market, Pedro Magalhaes, and other distinguished guests.… Continue reading Arctech Inaugurates New European Headquarters in Madrid, Paving the Way for a Grand European Expansion

China Matters’ Feature: How High-Quality Development Is Shaping China’s Future

BEIJING, Nov. 22, 2024 /PRNewswire/ — China has entered a transformative phase in its economic evolution, prioritizing sustainability and innovation over rapid growth. This strategic shift, known as high-quality development, represents a fundamental change aimed at ensuring long-term prosperity while addressing global challenges. Continue Reading China Matters’ Feature: How High-Quality Development Is Shaping China’s Future… Continue reading China Matters’ Feature: How High-Quality Development Is Shaping China’s Future

FUTURE FUND OMAN LAUNCHES FIRST WAVE OF INVESTMENT PROJECTS WORTH OVER US$ 2 BILLION

MUSCAT, Oman, Nov. 22, 2024 /PRNewswire/ — Future Fund Oman (FFO), the latest investment initiative under Oman Investment Authority (OIA), has announced its first batch of approved investment projects. With a combined value exceeding US$ 2 billion, these projects include US$ 1.6 billion committed by foreign investors and US$ 571 million contributed by FFO. The… Continue reading FUTURE FUND OMAN LAUNCHES FIRST WAVE OF INVESTMENT PROJECTS WORTH OVER US$ 2 BILLION

LONGi advocates for accelerating the energy just transition through green innovation at COP29

BAKU, Azerbaijan, Nov. 22, 2024 /PRNewswire/ — On November 11th, the 29th Conference of the Parties (COP29) to the United Nations Framework Convention on Climate Change kicked off in Baku, the capital of Azerbaijan. The conference focused on how to fairly and effectively allocate climate financing resources, ensuring that every penny can be used to… Continue reading LONGi advocates for accelerating the energy just transition through green innovation at COP29

Chongtai Yangtze River Tunnel: A Successful Trial of China’s Intelligent Shield Tunneling Technology

SHANGHAI, Nov. 22, 2024 /PRNewswire/ — China’s latest intelligent shield tunneling technology has been successfully applied in the Chongtai Yangtze River Tunnel, a key project for the Shanghai-Chongqing-Chengdu High Speed Railway. After working for over 2,000 meters, the shield tunnel intelligent construction V2.0 system was integrated into the “Pioneer” shield machine, significantly improving the efficiency and… Continue reading Chongtai Yangtze River Tunnel: A Successful Trial of China’s Intelligent Shield Tunneling Technology

Arctech Inaugurates New European Headquarters in Madrid, Paving the Way for a Grand European Expansion

MADRID, Nov. 22, 2024 /PRNewswire/ — Arctech, the world’s leading solar tracking and racking solutions provider, celebrated the relocation of its European headquarters in Madrid, Spain, on November 18th with a ribbon cutting ceremony. The event was attended by Chairman and President Cai Hao, General Manager of EU market, Pedro Magalhaes, and other distinguished guests.… Continue reading Arctech Inaugurates New European Headquarters in Madrid, Paving the Way for a Grand European Expansion

Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market

Bioretec Ltd Press release 22 November 2024 at 9:30 a.m.EET TAMPERE, Finland, Nov. 22, 2024 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with the next phase of the commercialization of its innovative RemeOs™ Trauma Products in the U.S. market. As a continuation to the previously signed… Continue reading Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market

FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer

NANJING, China, Nov. 22, 2024 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as “Leads Biolabs”) announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by the company with global intellectual property rights for the treatment of neuroendocrine cancer, has obtained Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA).… Continue reading FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer

Meet the 8849 TANK Pad: The World’s First 5G Rugged Projector Tablet

SHENZHEN, China, Nov. 22, 2024 /PRNewswire/ — Today, we are excited to announce our latest invention – 8849 Tank Pad, the world’s first 5G rugged projector tablet. It’s built to withstand extreme environments, ensuring uncompromising performance in the most challenging conditions. Whether on a worksite or in the wild, the 8849 Tank Pad delivers unmatched reliability… Continue reading Meet the 8849 TANK Pad: The World’s First 5G Rugged Projector Tablet

Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market

Bioretec Ltd Press release 22 November 2024 at 9:30 a.m.EET TAMPERE, Finland, Nov. 22, 2024 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with the next phase of the commercialization of its innovative RemeOs™ Trauma Products in the U.S. market. As a continuation to the previously signed… Continue reading Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market